Valuation : Repligen Corporation

Market Cap 9.29B 8.01B 7.58B 6.87B 12.89B 888B 12.97B 90.05B 34.6B 451B 34.9B 34.13B 1,427B P/E 2026 *
218x
P/E 2027 * 95.3x
Enterprise Value 9.03B 7.79B 7.37B 6.68B 12.52B 863B 12.6B 87.48B 33.62B 438B 33.91B 33.16B 1,386B EV / Sales 2026 *
10.9x
EV / Sales 2027 * 9.09x
Free-Float
94.31%
Yield 2026 *
-
Yield 2027 * -
1 day+0.30%
1 week-2.61%
Current month-8.73%
1 month+1.23%
3 months+26.32%
6 months+35.63%
Current year+0.81%
1 week 161.14
Extreme 161.1416
172.94
1 month 161.14
Extreme 161.1416
188.73
Current year 100.99
Extreme 100.99
188.73
1 year 100.99
Extreme 100.99
188.73
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Sell

Chief Executive Officer

-3,035 0.0054%
9/1/26 Tax

Controller/Auditor

-277 0.0005%
8/20/26 Exercice

Chief Executive Officer

16,278 0.0288%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%-2.61%+37.39%+2.33% 9.29B
-1.36%-6.29%-21.19%+1.21% 179B
-0.72%-2.30%-1.47%+13.76% 117B
+0.19%-4.64%+8.52%+80.96% 61.25B
-1.92%-7.24%+9.51%+41.28% 50.24B
+0.81%-5.21%-5.61%-33.33% 48.05B
-1.75%-7.45%+9.25%-20.43% 31.89B
+0.43%-11.10% - - 28.42B
+0.58%+1.02%+35.66%-11.94% 24.23B
+0.49%-8.98%-13.28%+5.27% 21.4B
Average -0.29%-5.11%+6.53%+8.79% 57.08B
Weighted average by Cap. -0.68%-4.25%-3.71%+11.90%

Financials

2026 *2027 *
Net sales 827M 713M 675M 611M 1.15B 79.01B 1.15B 8.01B 3.08B 40.15B 3.11B 3.04B 127B 974M 840M 795M 720M 1.35B 93.1B 1.36B 9.44B 3.63B 47.31B 3.66B 3.58B 150B
Net income 41.92M 36.15M 34.21M 30.99M 58.14M 4.01B 58.48M 406M 156M 2.04B 157M 154M 6.44B 98.84M 85.24M 80.66M 73.07M 137M 9.44B 138M 958M 368M 4.8B 371M 363M 15.18B
Net Debt -265M -228M -216M -196M -367M -25.31B -370M -2.57B -986M -12.86B -995M -973M -40.67B -438M -378M -357M -324M -607M -41.85B -611M -4.24B -1.63B -21.27B -1.64B -1.61B -67.26B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-09-11 $165.18 +0.30% 938,043
26-09-10 $164.68 -0.22% 955,980
26-09-09 $165.05 -2.06% 1,081,203
26-09-08 $168.53 +0.55% 779,443
26-09-04 $167.60 -1.19% 806,066
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
164.68USD
Average target price
189.48USD
Spread / Average Target
+15.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!